Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Gross Profit (2022)

Updated

Pasithea Therapeutics (KTTA) recorded Gross Profit of $242,020 in Q4 2022, up 83.2% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Gross Profit (2022) Analysis & Trends

For FY2022, Pasithea Therapeutics reported Gross Profit of $373,364.

  • Across earlier years, Gross Profit came in at -$2,213 in FY2021.
  • Per Business Quant, the preceding three quarters came in at $132,143 (Q3 2022), -$1,520 (Q2 2022) and $721.00 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 242,020.00
Sep 30, 2022 132,143.00
Jun 30, 2022 -1,520.00
Mar 31, 2022 721.00
API Access

Pasithea Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KTTA&period=max&api_key=YOUR_API_KEY